Legionella Testing Market Size To Reach $491.0 Million By 2030

Legionella Testing Market Growth & Trends

The global legionella testing market size is expected to reach USD 491.0 million by 2030, registering a CAGR of 8.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of Legionella-related disorders, along with requirements of rapid diagnostic procedures, is expected to drive the industry growth.

According to the CDC, the number of people suffering from Legionnaires’ disease was 4,548 in 2013. The incidence of pneumonia and related disorders is constantly rising due to the contaminated environment. The rising incidence of Legionellosis will drive market growth in the coming years, especially in the industrial sector.

The conventional bacterial testing is least preferred nowadays since it is labor-intensive and time-consuming. Against the difficulties faced due to the conventional microbial testing methods, rapid automated tests are gaining popularity in the industry.

 Request a free sample copy or view report summary: Legionella Testing Market Report

Legionella Testing Market Report Highlights

• The water testing segment held the largest revenue share in 2022. The factors contributing to the segment growth mainly include government laws that mandate the testing for Legionella

• Water testing has also been projected as the fastest-growing segment over the forecast period followed by IVD testing

• The microbial culture segment accounted for the largest revenue share of 37.4% in 2022. Microbial culture offers high specificity and sensitivity, accurately identifying Legionella bacteria.

• The PCR segment is expected to grow at the fastest CAGR of 8.8% during the forecast period. PCR provides benefits such as timely and accurate diagnosis along with reproducible results. Hence, it is preferred as a bacterial testing method.

Legionella Testing Market Segmentation

Grand View Research has segmented the global legionella testing market on the basis of on type, end-use, and region:

Legionella Testing Type Outlook (Revenue, USD Million, 2018 - 2030)

• Water Testing

• IVD Testing

Legionella Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Microbial Culture

• Direct Fluorescent Antibody (DFA) Stain

• PCR

• Others (Serotyping)

Legionella Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Legionella Testing Market

• Abbott

• Beckman Coulter, Inc.

• BD

• Bio-Rad Laboratories, Inc.

• BIOMÉRIEUX

• Eiken Chemical Co., Ltd.

• Hologic, Inc.

• Pro Lab Diagnostics Inc.

• QIAGEN

• F. Hoffmann-La Roche Ltd.

• Takara Bio Inc.

• Thermo Fisher Scientific Inc.